首页> 外文OA文献 >Quality of Life with Ivabradine in Patients with Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the i f Inhibitor Ivabradine in Patients with Coronary Artery Disease Quality of Life Substudy

【2h】

Quality of Life with Ivabradine in Patients with Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the i f Inhibitor Ivabradine in Patients with Coronary Artery Disease Quality of Life Substudy

机译：Ivabradine治疗冠心病心绞痛的生活质量：评估抑制剂Ivabradine在冠心病患者中的发病率 - 死亡率益处的研究生活质量亚组研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tendera, Michal; Chassany, Olivier; Ferrari, Roberto; Ford, Ian; Steg, Philippe Gabriel; Tardif, Jean-Claude; Fox, Kim;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Quality of Life with Ivabradine in Patients with Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the i f Inhibitor Ivabradine in Patients with Coronary Artery Disease Quality of Life Substudy [J] . Circulation. Cardiovascular quality and outcomes . 2016,第1期

机译：伊伐布雷定治疗心绞痛患者的生活质量：评估伊伐布雷定抑制剂伊伐布雷定在冠状动脉疾病患者中的发病率和死亡率的研究生活质量研究
2. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究的基本原理，设计和基线特征评估了冠状动脉疾病患者中If抑制剂ivabradine的发病率-死亡率（SIGNIFY试验）：稳定冠心病患者使用ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
3. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究评估冠状动脉疾病患者抑制剂IVABRADINE的发病率，设计和基线特征，评估冠状动脉疾病患者的发病率 - 死亡率（意思是试验）：稳定冠状动脉患者Ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
4. Study on the Effects of Long-Term Aerobic Exercise Combined with Resistance Training on Cardiac Function, Exercise Tolerance and Quality of Life in Patients with Myocardial Ischemia caused by Coronary Artery Disease [C] . Yuan Zhang International Conference on Innovations in Economic Management and Social Science . 2017

机译：长期好氧运动与冠状动脉疾病患者心功能，运动耐受性和生活质量的影响研究
5. The relationship between coping, anxiety, and quality of life for Taiwanese post-coronary artery bypass graft surgery patients. [D] . Tung, Heng-Hsin. 2007

机译：台湾冠状动脉旁路移植术后患者应对，焦虑与生活质量之间的关系。
6. Characteristics treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study [O] . Leonardo De Luca, Pier Luigi Temporelli, Donata Lucci, -1

机译：稳定型冠心病伴或不伴心绞痛的患者的特征治疗和生活质量：START研究的启示
7. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [O] . Fox, K., Ford, I., Steg, P.G., 2013

机译：研究的基本原理，设计和基线特征评估冠状动脉疾病患者If抑制剂伊伐布雷定的发病率 - 死亡率beNefits（sIGNIFY试验）：稳定冠状动脉患者的伊伐布雷定随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病

Quality of Life with Ivabradine in Patients with Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the i f Inhibitor Ivabradine in Patients with Coronary Artery Disease Quality of Life Substudy

著录项

相似文献

相关主题

期刊订阅